Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price traded down 0.6% on Tuesday . The company traded as low as $141.00 and last traded at $141.00. 200 shares traded hands during trading, a decline of 71% from the average daily volume of 693 shares. The stock had previously closed at $141.81.
Analyst Ratings Changes
Separately, Jefferies Financial Group downgraded Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $155.00.
Read Our Latest Stock Report on PMCUF
Pro Medicus Price Performance
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Further Reading
- Five stocks we like better than Pro Medicus
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
